Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents (Q28282770)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents	scientific article

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Tobias Banaschewski

3

0 references

4

0 references

object named as

David Coghill

5

0 references

Samuele Cortese

object named as

Samuele Cortese

1

0 references

Ralf W. Dittmann

7

object named as

Ralf W Dittmann

0 references

Martin Holtmann

2

object named as

Martin Holtmann

0 references

Marina Danckaerts

6

object named as

Marina Danckaerts

0 references

author name string

John Graham

8

0 references

Eric Taylor

9

0 references

Joseph Sergeant

10

0 references

language of work or name

0 references

publication date

March 2013

0 references

The Journal of Child Psychology and Psychiatry

0 references

54

0 references

227-46

0 references

3

0 references

Long-term safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: an open-label, dose-titration, 1-year study.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Does Attention Deficit Hyperactivity Disorder increase the risk of suicide attempts?

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Depression and suicide in adolescents with epilepsy

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Meta-analysis of suicide-related behavior events in patients treated with atomoxetine

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Global issues related to the impact of untreated attention-deficit/hyperactivity disorder from childhood to young adulthood

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Once-daily atomoxetine for treating pediatric attention-deficit/hyperactivity disorder: comparison of morning and evening dosing.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Hyperactive night and day? Actigraphy studies in adult ADHD: a baseline comparison and the effect of methylphenidate.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Hallucinations associated with initiation of guanfacine

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Very early predictors of adolescent depression and suicide attempts in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

ADHD drugs and serious cardiovascular events in children and young adults

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Modeled economic evaluation of alternative strategies to reduce sudden cardiac death among children treated for attention deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Clonidine abuse among opiate addicts

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

New-onset seizures: a possible association with clonidine?

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Comorbidity of ADHD and Substance Use Disorder (SUD): a neuroimaging perspective

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Antidepressants and psychostimulants in pediatric populations: is there an association with mania?

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Sudden death and use of stimulant medications in youths.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

European guidelines on managing adverse effects of medication for ADHD.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective?

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Association between attention-deficit/hyperactivity disorder and epilepsy in pediatric populations

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Increased frequency of rolandic spikes in ADHD children.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Pharmacological treatment of ADHD and the short and long term effects on sleep

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Abuse liability assessment of atomoxetine in a drug-abusing population

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Attention deficit and hyperactivity disorder in people with epilepsy: diagnosis and implications to the treatment

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Efficacy and safety of methylphenidate in treating ADHD symptoms in children and adolescents with uncontrolled seizures: a Brazilian sample study and literature review

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Sleep and ADHD.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Cardiac screening prior to stimulant treatment of ADHD: a survey of US-based pediatricians.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Critical review of data supporting affective disorder caused by nonpsychotropic medication

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Does guanfacine cause hallucinations in children?

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Weekend holidays during methylphenidate use in ADHD children: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

The use, misuse and diversion of prescription stimulants among middle and high school students.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Hallucinations and Other Psychotic Symptoms Associated With the Use of Attention-Deficit/Hyperactivity Disorder Drugs in Children

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Growth on stimulant medication; clarifying the confusion: a review

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Guanfacine extended-release for attention-deficit/hyperactivity disorder (ADHD).

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Cardiovascular events and death in children exposed and unexposed to ADHD agents

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Is ADHD a risk factor independent of conduct disorder for illicit substance use? A meta-analysis and metaregression investigation.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

ADHD treatments, sleep, and sleep problems: complex associations

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Melatonin for treatment of sleeping disorders in children with attention deficit/hyperactivity disorder: a preliminary open label study.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

The intersection of attention-deficit/hyperactivity disorder and substance abuse

1 reference

https://api.crossref.org/works/10.1111%2FJCPP.12036

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28282770&oldid=1971929093"